Oramed Pharmaceuticals Inc (ORMP) — Capital Reinvestment Ratio
Oramed Pharmaceuticals Inc (ORMP) has a Capital Reinvestment Ratio of 0.00x as of June 2024, meaning it reinvests 0% of its operating cash flow ($2.07 Million) in capital expenditures ($17.06). Check Oramed Pharmaceuticals Inc (ORMP) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Oramed Pharmaceuticals Inc Capital Reinvestment Ratio (2016–2016)
This chart tracks Oramed Pharmaceuticals Inc's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Oramed Pharmaceuticals Inc.
Annual Capital Reinvestment Ratio for Oramed Pharmaceuticals Inc (2016–2016)
Year-by-year Capital Reinvestment Ratio for Oramed Pharmaceuticals Inc from 2016 to 2016. See Oramed Pharmaceuticals Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2016 | 0.00x | $4.66 Million | $9.00K | — |